Mesenchymal chondrosarcoma is a distinct histological subtype of chondrosarcoma. This scenario requires a specific clinical approach, and management decisions depend on the features and extent of the disease in this setting.
Patients with mesenchymal chondrosarcoma may be considered for adjuvant or neoadjuvant chemotherapy as part of their overall care plan, alongside surgical considerations.
Surgical management is a key component of the approach in this setting. The complete evidence-based regimen — including the full sequence of interventions and clinical decision points — is available in the structured protocol.
DOI: 10.1038/s41416-024-02868-4
Patients with mesenchymal chondrosarcoma may be considered for adjuvant or neoadjuvant chemotherapy.
Local recurrence of chondrosarcoma is best treated by further wide excision.
View source ↗